Pasadena, CA, United States of America

Emily Elizabeth Lee

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Acurastem, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emily Elizabeth Lee. Retrieved from https://idiyas.com/inventor/emily-elizabeth-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emily Elizabeth Lee: Innovator in Neurological Treatments

Introduction

Emily Elizabeth Lee is a prominent inventor based in Pasadena, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurological diseases. Her innovative work has garnered attention in the scientific community.

Latest Patents

Emily holds a patent for PIKFYVE antisense oligonucleotides. This invention relates to pharmaceutical compositions containing these oligonucleotides and methods for treating, inhibiting, suppressing, and preventing neurological diseases. Her patent represents a crucial advancement in the treatment of complex neurological conditions.

Career Highlights

Emily is currently associated with Acurastem, Inc., where she continues to push the boundaries of medical research. Her dedication to improving patient outcomes through innovative therapies is evident in her work and research.

Collaborations

Emily collaborates with Wen-Hsuan Chang, a fellow researcher, to further enhance the impact of their work in the field of neurological treatments.

Conclusion

Emily Elizabeth Lee's contributions to the field of pharmaceuticals, particularly through her patent on PIKFYVE antisense oligonucleotides, highlight her role as a key innovator in the treatment of neurological diseases. Her ongoing work at Acurastem, Inc. promises to lead to further advancements in this critical area of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…